SBIR/STTR Research Award

PURA COMPLEMENTATION FOR PLASMID SELECTION & MAINTENANCE

Award identifier fb07e1e2c0dbe006316028a360a98d17b5ba4b5b0e4497108e670b2700f1decbAwarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1988

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Praxis Biologics Inc
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

LIVE ATTENUATED SALMONELLA STRAINS ARE BEING INVESTIGATED ASVECTORS FOR THE DELIVERY OF FOREIGN ANTIGENS TO STIMULATE A PROTECTIVE IMMUNE RESPONSE AGAINST VARIOUS BACTERIAL, VIRAL,AND PROTOZOAN DISEASES. THESE ORAL VACCINES CURRENTLY UNDERDEVELOPMENT RELY ON EXPRESSION OF FOREIGN ANTIGENS FROM PLASMID VECTORS WHICH ALSO ENCODE AMPICILLIN RESISTANCE. ITIS UNLIKELY THAT A VACCINE STRAIN CARRYING A FUNCTIONAL ANTIBIOTIC GENE WILL BE ACCEPTABLE TO THE REGULATORY AGENCIES OR TO THE PUBLIC AT LARGE. THIS PROPOSAL IS TO EXAMINE THE FEASIBILITY OF AN ALTERNATIVE SELECTION SYSTEM WHICH SHOULD SELECTIVELY MAINTAIN THE PLASMID IN THE ABSENCE OF ANY EXOGENOUSLY APPLIED SELECTIVE PRESSURE. COMPLEMENTATION OF A PURA DEFECT IN THE BACTERIAL HOST CHROMOSOME BY A PLASMID EXPRESSING ACTIVE ADENYLSUCCINATE SYNTHETASE (PURA+) SHOULD PROVIDE A POWERFUL SELECTION FOR MAINTENANCE OF THE PLASMID VECTOR. THIS STUDY WILL DETERMINE WHETHER SELECTION OF PURINE INDEPENDENCE COULD SUBSTITUTE FOR STANDARD AMPICILLINSELECTION IN SMALL SCALE LIQUID CULTURE OF S. TYPHIMURIUM AND S. DUBLIN VACCINE STRAINS IN THE LABORATORY, IN 10L SCALE FERMENTATION, AND IN VIVO IN THE MOUSE MODEL SYSTEM. SUCCESSFUL DEMONSTRATION OF SELECTIVE MAINTENANCE OF PURA PLASMID BEARING STRAINS IN CULTURE AND IN VIVO WILL LEAD TO CLINICAL TRIALS OF PURA PLASMIDS IN LIVE ORAL BACTERIAL VACCINES.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.